Malme KB, Stene-Johansen K, Klundby I, Backe Ø, Foshaug T, Greve MH, Pihl CM, Finbråten AK, Dalgard O, Midgard H(2024) Virologic Response and Reinfection Following HCV Treatment among Hospitalized People Who Inject Drugs: Follow-Up Data from the OPPORTUNI-C Trial Viruses, 16(6) DOI 10.3390/v16060858, PubMed 38932151
Strande V, Lund C, Hagen M, Bengtson MB, Cetinkaya RB, Detlie TE, Frigstad SO, Høie O, Medhus AW, Henriksen M, Aass Holten KI, Hovde Ø, Huppertz-Hauss G, Johansen I, Olsen BC, Opheim R, Ricanek P, Torp R, Tønnessen T, Vatn S, Aabrekk TB, Høivik ML, Kristensen VA(2024) Clinical course of ulcerative colitis: Frequent use of biologics and low colectomy rate first year after diagnosis-results from the IBSEN III inception cohort Aliment Pharmacol Ther(in press) DOI 10.1111/apt.18097, PubMed 38837289
Midgard H, Malme KB, Finbråten AK, Dalgard O(2024) Treatment completion and SVR in the context of HCV elimination: Time to let go of the reins? Clin Infect Dis(in press) DOI 10.1093/cid/ciae298, PubMed 38824443